A nursing student asks about the differences between cell-cycle phase–specific chemotherapeutic agents and those that are cell-cycle phase nonspecific. What will the nurse explain?
a. Cell-cycle phase–nonspecific drugs are less toxic.
b. Cell-cycle phase–specific drugs do not harm "resting" cells.
c. Cell-cycle phase–specific drugs should be given at specific intervals.
d. Neither type is toxic to cells in the "rest-ing" G0 phase.
B
Cell-cycle phase–specific drugs do not harm "resting" cells, because these drugs are toxic only to cells that are active participants in the cell cycle. Cell-cycle phase–nonspecific drugs are not less toxic than cell-cycle phase–specific agents. Cell-cycle phase–specific drugs are usually given by prolonged infusion. Cell-cycle phase–nonspecific drugs are toxic to "resting" cells.
You might also like to view...
A nurse comes to the mental health clinic tired, angry, and in a hurry
After making several minor mistakes, the nurse realizes that in order to help clients and improve their functioning through the development of behavioral contracts, he/she must first take his/her time and change his/her attitude in order to: 1. Formulate practical and measurable objectives. 2. Develop goals based on client and family needs. 3. Normalize the family's experience. 4. Teach the client communication skills.
Which patient(s) would the nurse consider to be at risk for not understanding informed consent information because of health illiteracy? Select all that apply
1. A 50-year-old who works in a manufacturing plant 2. A 23-year-old who works at a fast-food restaurant 3. A 35-year-old immigrant from China 4. A 19-year-old high school graduate 5. A 77-year-old who has long-standing diabetes mellitus
Which clinical manifestation in a client with invasive cervical cancer alerts the nurse to the possibility of metastasis?
a. Amenorrhea b. Weight gain c. Breast tenderness d. Swelling of one leg
A patient with heart failure is receiving dobutamine (Dobutrex) intravenously at home. Which sign or symptom should the patient and family be instructed to report to the prescriber immediately?
a. Burning or pain at the intravenous (IV) site b. Heart rate between 60 and 70 beats/min c. Urine output of 1600 mL over 24 hours d. Brief episode of shortness of breath